Ciclosporin in psoriasis clinical practice: an international consensus statement

  1. C.E.M. Griffiths,
  2. L. Dubertret,
  3. C.N. Ellis,
  4. A.Y. Finlay,
  5. A.F. Finzi,
  6. V.C. Ho,
  7. A. Johnston,
  8. A. Katsambas,
  9. A-E. Lison,
  10. J.M. Naeyaert,
  11. H. Nakagawa,
  12. C. Paul,
  13. F. Vanaclocha

Article first published online: 29 APR 2004

DOI: 10.1111/j.0366-077X.2004.05949.x

Issue

British Journal of Dermatology

British Journal of Dermatology

Volume 150, Issue Supplement s67, pages 11–23, May 2004

Additional Information

How to Cite

Griffiths, C.E.M., Dubertret, L., Ellis, C.N., Finlay, A.Y., Finzi, A.F., Ho, V.C., Johnston, A., Katsambas, A., Lison, A.-E., Naeyaert, J.M., Nakagawa, H., Paul, C. and Vanaclocha, F. (2004), Ciclosporin in psoriasis clinical practice: an international consensus statement. British Journal of Dermatology, 150: 11–23. doi: 10.1111/j.0366-077X.2004.05949.x

Author Information

  1. Dermatology Centre, University of Manchester, Hope Hospital, Manchester, UK *Skin Research Institute and Dermatology, Saint Louis University Hospital, Paris, France †Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA ‡Department of Dermatology, University of Wales College of Medicine, Cardiff, UK §Department of Dermatology, University of Milan, Milan, Italy ¶Division of Dermatology, University of British Columbia, Vancouver, British Columbia, Canada **Clinical Pharmacology, Barts and The London, University of London, UK ††Department of Dermatology, University of Athens, A.Sygros Hospital, Athens, Greece ‡‡Department of Nephrology and Transplantation, Medizinische Klinik III, Zentralkrankenhaus, Bremen, Germany §§Department of Dermatology, Ghent University Hospital, Gent, Belgium ¶¶Department of Dermatology, Jichi Medical School, Tochigi, Japan ***Clinical Research Department, Novartis Pharma AG, Basel, Switzerland, and Department of Dermatology, Mulhouse General Hospital, Mulhouse, France †††Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain

*Professor Christopher Griffiths, Dermatology Centre, University of Manchester Irving Building, Hope Hospital, Salford, Manchester, M6 8HD, UK. E-mail: christopher.griffiths@man.ac.uk.

  1. This report has been generated from the ‘Ciclosporin in Psoriasis Clinical Practice’ consensus conference held in Paris, France, on 5 September 2003. It involved experts in dermatology, clinical pharmacology and nephrology. The purpose of the conference was to develop a consensus statement on the clinical role of ciclosporin in the treatment of psoriasis. This conference was supported by an unrestricted educational grant from Novartis Pharma AG.

Publication History

  1. Issue published online: 29 APR 2004
  2. Article first published online: 29 APR 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (212K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (212K)